Nicholas Lintzeris

Summary

Affiliation: King's College London
Country: UK

Publications

  1. ncbi Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial
    Nicholas Lintzeris
    National Addiction Centre, 4 Windsor Walk, Denmark Hill, London SE5 8AF, United Kingdom
    Am J Addict 13:S29-41. 2004
  2. ncbi A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal
    Nicholas Lintzeris
    Turning Point Alcohol and Drug Centre, Fitzroy, Victoria, Australia
    Addiction 97:1395-404. 2002
  3. ncbi Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom-triggered dose titration study
    Nicholas Lintzeris
    Turning Point Alcohol and Drug Centre, Victoria, Australia
    Drug Alcohol Depend 70:287-94. 2003
  4. ncbi Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients
    Nicholas Lintzeris
    National Addiction Center, Institute of Psychiatry, King s College London, London, England
    J Clin Psychopharmacol 26:274-83. 2006
  5. ncbi Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients
    Nicholas Lintzeris
    National Addiction Centre, Institute of Psychiatry, Kings College London, and South London and Maudsley NHS Trust, P O Box 48, 4 Windsor Walk, Denmark Hill, London SE5 8AF, United Kingdom
    Drug Alcohol Depend 91:187-94. 2007
  6. ncbi Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics
    Teodora Groshkova
    National Addiction Centre, King s College London, London, UK European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal
    Drug Alcohol Rev 32:566-73. 2013
  7. ncbi Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction
    Sarah Byford
    Sarah Byford, PhD, Barbara Barrett, PhD, Centre for the Economics of Mental and Physical Health, Institute of Psychiatry, King s College London, UK Nicola Metrebian, PhD, Addictions Department, National Addiction Centre, Institute of Psychiatry, King s College London, UK Teodora Groshkova, PhD, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal Maria Cary, MSc, Centre for the Economics of Mental and Physical Health, Institute of Psychiatry, King s College London, UK Vikki Charles, MA, Addictions Department, National Addiction Centre, Institute of Psychiatry, King s College London, UK Nicholas Lintzeris, PhD, The Langton Centre, South Eastern Sydney Local Health District, NSW Health, Australia John Strang, MD, Addictions Department, National Addiction Centre, Italy
    Br J Psychiatry 203:341-9. 2013
  8. ncbi A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia
    Alison J Ritter
    Turning Point Alcohol and Drug Centre, Fitzroy, Victoria, Australia
    Addiction 98:1605-13. 2003
  9. ncbi Feasibility and acceptability of an intranasal diamorphine spray as an alternative to injectable diamorphine for maintenance treatment
    Timothy B Mitchell
    National Addiction Centre, Institute of Psychiatry, King s College, and South London and Maudsley NHS Trust, London, UK
    Eur Addict Res 12:91-5. 2006
  10. doi Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence
    Gayle Ridge
    National Addiction Centre, Maudsley Hospital Institute of Psychiatry, King s College, London, UK
    J Subst Abuse Treat 37:95-100. 2009

Detail Information

Publications21

  1. ncbi Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial
    Nicholas Lintzeris
    National Addiction Centre, 4 Windsor Walk, Denmark Hill, London SE5 8AF, United Kingdom
    Am J Addict 13:S29-41. 2004
    ..Integration of treatment systems (methadone with buprenorphine, specialist and primary-care programs) and factors thought to be important in the uptake of buprenorphine treatment in Australia since registration are discussed...
  2. ncbi A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal
    Nicholas Lintzeris
    Turning Point Alcohol and Drug Centre, Fitzroy, Victoria, Australia
    Addiction 97:1395-404. 2002
    ..To determine whether buprenorphine is more effective than clonidine and other symptomatic medications in managing ambulatory heroin withdrawal...
  3. ncbi Buprenorphine dosing regime for inpatient heroin withdrawal: a symptom-triggered dose titration study
    Nicholas Lintzeris
    Turning Point Alcohol and Drug Centre, Victoria, Australia
    Drug Alcohol Depend 70:287-94. 2003
    ..A dosing regime using sublingual buprenorphine tablets for short inpatient heroin withdrawal is proposed...
  4. ncbi Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients
    Nicholas Lintzeris
    National Addiction Center, Institute of Psychiatry, King s College London, London, England
    J Clin Psychopharmacol 26:274-83. 2006
    ..Diazepam may significantly alter the response to opioid substitution treatment with methadone or buprenorphine...
  5. ncbi Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients
    Nicholas Lintzeris
    National Addiction Centre, Institute of Psychiatry, Kings College London, and South London and Maudsley NHS Trust, P O Box 48, 4 Windsor Walk, Denmark Hill, London SE5 8AF, United Kingdom
    Drug Alcohol Depend 91:187-94. 2007
    ..Benzodiazepine abuse is common among methadone- and buprenorphine-maintained patients; however interactions between these drugs under high dose conditions have not been adequately examined under controlled conditions...
  6. ncbi Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics
    Teodora Groshkova
    National Addiction Centre, King s College London, London, UK European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal
    Drug Alcohol Rev 32:566-73. 2013
    ....
  7. ncbi Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction
    Sarah Byford
    Sarah Byford, PhD, Barbara Barrett, PhD, Centre for the Economics of Mental and Physical Health, Institute of Psychiatry, King s College London, UK Nicola Metrebian, PhD, Addictions Department, National Addiction Centre, Institute of Psychiatry, King s College London, UK Teodora Groshkova, PhD, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal Maria Cary, MSc, Centre for the Economics of Mental and Physical Health, Institute of Psychiatry, King s College London, UK Vikki Charles, MA, Addictions Department, National Addiction Centre, Institute of Psychiatry, King s College London, UK Nicholas Lintzeris, PhD, The Langton Centre, South Eastern Sydney Local Health District, NSW Health, Australia John Strang, MD, Addictions Department, National Addiction Centre, Italy
    Br J Psychiatry 203:341-9. 2013
    ..Despite evidence of the effectiveness of injectable opioid treatment compared with oral methadone for chronic heroin addiction, the additional cost of injectable treatment is considerable, and cost-effectiveness uncertain...
  8. ncbi A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia
    Alison J Ritter
    Turning Point Alcohol and Drug Centre, Fitzroy, Victoria, Australia
    Addiction 98:1605-13. 2003
    ..The present study aimed to compare the efficacy of levo-alpha-acetylmethadol (LAAM) and methadone, as measured by retention in treatment and heroin use, in a randomized trial conducted under naturalistic conditions...
  9. ncbi Feasibility and acceptability of an intranasal diamorphine spray as an alternative to injectable diamorphine for maintenance treatment
    Timothy B Mitchell
    National Addiction Centre, Institute of Psychiatry, King s College, and South London and Maudsley NHS Trust, London, UK
    Eur Addict Res 12:91-5. 2006
    ..IN administration may be an alternative or supplementary form of diamorphine maintenance and deserves serious further investigation...
  10. doi Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence
    Gayle Ridge
    National Addiction Centre, Maudsley Hospital Institute of Psychiatry, King s College, London, UK
    J Subst Abuse Treat 37:95-100. 2009
    ..Buprenorphine was more likely to be prescribed for short-term detoxification and methadone for maintenance treatment...
  11. ncbi Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial
    John Strang
    King s College London, National Addiction Centre, London, UK
    Lancet 375:1885-95. 2010
    ..We aimed to compare the effectiveness of supervised injectable treatment with medicinal heroin (diamorphine or diacetylmorphine) or supervised injectable methadone versus optimised oral methadone for chronic heroin addiction...
  12. ncbi Buprenorphine dosing regime in the management of out-patient heroin withdrawal
    Nicholas Lintzeris
    Turning Point Alcohol and Drug Centre and Australian National University, Victoria, Australia
    Drug Alcohol Rev 21:39-45. 2002
    ..Five subjects reported no heroin use, and five subjects reported using on only one occasion during the 8 days. An out-patient buprenorphine regime is recommended...
  13. ncbi Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose
    Nicolas C Clark
    Turning Point Alcohol and Drug Centre, Fitzroy, Vic
    Med J Aust 176:166-7. 2002
    ..This case highlights features of the unique pharmacology of buprenorphine and some key issues for its use in the management of heroin dependence...
  14. ncbi Training primary health care professionals to provide buprenorphine and LAAM treatment
    Nicholas Lintzeris
    Turning Point Alcohol and Drug Centre, Melbourne, Australia
    Subst Abus 23:245-54. 2002
    ..Findings of the evaluation of these initiatives and the subsequent Australian postregistration training program for buprenorphine are described...
  15. doi "Should I stay or should I go?" Coming off methadone and buprenorphine treatment
    Adam R Winstock
    National Addiction Centre, Institute of Psychiatry, King s College London, 4 Windsor Walk, London, UK
    Int J Drug Policy 22:77-81. 2011
    ..The study explored previous experiences, current interest and concerns about stopping treatment, and perceptions of how and when coming off treatment should be supported...
  16. doi Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?
    Suzanne Nielsen
    Clinical Research, Turning Point Alcohol and Drug Centre, Melbourne, Australia
    Drug Alcohol Rev 30:291-9. 2011
    ..The aim of this study was to compare those presenting for treatment where heroin versus POA were the primary drugs of concern...
  17. ncbi Unplanned admissions to two Sydney public hospitals after naltrexone implants
    Nicholas Lintzeris
    Drug Health Services, Sydney South West Area Health Service, Sydney, NSW
    Med J Aust 188:441-4. 2008
    ..To describe hospital presentations related to the use of naltrexone implants, an unlicensed product used in Australia for treating heroin dependence...
  18. ncbi Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions
    Courtney L Breen
    National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Sydney, Australia
    Drug Alcohol Depend 71:49-55. 2003
    ..Buprenorphine is used in the treatment of opioid dependence. Due to its pharmacology, the transfer from methadone to buprenorphine may precipitate withdrawal symptoms...
  19. ncbi A comparison of buprenorphine treatment in clinic and primary care settings: a randomised trial
    Amy E Gibson
    National Drug and Alcohol Research Centre, University of New South Wales, UNSW Randwick Campus, King Street, Randwick, NSW 2052, Australia
    Med J Aust 179:38-42. 2003
    ..To compare outcomes, costs and incremental cost-effectiveness of heroin detoxification performed in a specialist clinic and in general practice...
  20. ncbi Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project
    Erol Digiusto
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia
    Addict Behav 30:443-56. 2005
    ....